India Cord Blood Transplant About Cord Blood: Your baby's umbilical cord blood is a valuable source of
stem cells, which are genetically unique to your baby and family. Red Blood Cells - which carry oxygen to all the cells in the body There are three sources where stem cells are commonly found, they are: Bone Marrow The ability of cord blood stem cells to differentiate, or change into other types of cells in the body is a new discovery that holds significant promise for improving the treatment of some of the most common diseases such as heart disease, stroke, and Alzheimer's. Today, stem cell therapy is
a major breakthrough in regenerative medical research. Stem cells have the
potential to help cure many life-threatening ailments like leukemia,
non-Hodgkin's lymphoma, anemia, inherited disorders and all other
deficiencies of the immune system. Lifestyle diseases such as diabetes,
liver disorders and heart ailments can also be treated with stem cells.
Cord blood is also "privileged" or unexposed to most diseases that make bone marrow from an adult more difficult to use in transplantation. More importantly, cord blood from your baby is a perfect match for your child, if it ever should be needed, and has a 1 - in - 4 chance of matching a current or future sibling. Childbirth is thus a once-in-a-lifetime opportunity to collect and preserve these stem cells and harness what is otherwise discarded as bio-medical waste. So, when you preserve your baby's cord blood stem cells, you ensure your family the gift of life. Processing Cord Blood Your baby's cord blood sample is stored in multiple cryovials. On an average, we store cryovials of each cord blood sample. This provides the families a significant benefit in the future, since the cells may be used for more than one treatment. Each vial is bar coded and clearly marked with: Cord Blood Identifying Number, Account Number, Date of Processing and Contents. Each vial is individually wrapped using a cryo sheathing to protect against cross-contamination. Your vials then enter the first stage of the cryopreservation, with a slow-rate introduction to the freezing process. Most of the present day Cord Blood Registry uses this technique of slow-rate introduction to ensure the safety of the cells. The progression to lower and lower temperatures keeps the cells from going into shock from the extreme negative temperature of -196° Celsius. Screening Storage Cord blood stem cells are preferred over bone marrow stem cells (for transplantation) and have already been used to treat numerous types of malignancies including certain kinds of leukemia, Hodgkin's disease and other types of lymphoma. It has also been used for the treatment of a variety of anemia, inherited metabolic disorders and deficiencies of the immune system.
Umbilical cord blood stem cell was first used
for transplantation in 1988, in France, for a patient with Fanconi's
anemia. Since that time, cord blood stem cell has been increasingly used
as a substitute for bone marrow in thousand of successful transplants.
Cord blood stem cell transplants are known to
be as successful as bone marrow in the cases in which they have been
used. Moreover cord blood has other advantages over bone marrow,
including ease of collection and better tolerance of HLA mismatches.
|